Stay updated on DUET Clinical Trial: Sparsentan in FSGS.
Sign up to get notified when there's something new on the DUET Clinical Trial: Sparsentan in FSGS. page.

Latest updates to the DUET Clinical Trial: Sparsentan in FSGS. page
- Check6 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the previous detailed content of the trial. This blocks access to sections like study details, interventions, eligibility criteria, and locations, leaving only an error screen with a Home link.SummaryDifference19%

- Check13 days agoChange DetectedRevision label on the page updated from v3.6.6 to v3.7.0, reflecting a platform maintenance release. It does not modify study data or text.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s Revision tag was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This change affects only the metadata label and does not modify the substantive study details.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision history shows Revision: v3.6.5, replacing the previous v3.6.4, indicating a recent update to the study page.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.6.4 appears in the page footer, replacing Revision: v3.6.3. This change reflects a minor version update and does not modify study content or user-facing functionality.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page's revision metadata was updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page version.SummaryDifference0.0%

Stay in the know with updates to DUET Clinical Trial: Sparsentan in FSGS.
Enter your email address, and we'll notify you when there's something new on the DUET Clinical Trial: Sparsentan in FSGS. page.